BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15639652)

  • 1. Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients.
    van der Vliet HJ; Molling JW; von Blomberg BM; Kölgen W; Stam AG; de Gruijl TD; Mulder CJ; Janssen HL; Nishi N; van den Eertwegh AJ; Scheper RJ; van Nieuwkerk CJ
    Clin Immunol; 2005 Feb; 114(2):183-9. PubMed ID: 15639652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15.
    van der Vliet HJ ; Nishi N; Koezuka Y; von Blomberg BM ; van den Eertwegh AJ ; Porcelli SA; Pinedo HM; Scheper RJ; Giaccone G
    J Immunol Methods; 2001 Jan; 247(1-2):61-72. PubMed ID: 11150537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity.
    Nieda M; Okai M; Tazbirkova A; Lin H; Yamaura A; Ide K; Abraham R; Juji T; Macfarlane DJ; Nicol AJ
    Blood; 2004 Jan; 103(2):383-9. PubMed ID: 14512316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
    Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
    Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection.
    van der Vliet HJ; von Blomberg BM; Hazenberg MD; Nishi N; Otto SA; van Benthem BH; Prins M; Claessen FA; van den Eertwegh AJ; Giaccone G; Miedema F; Scheper RJ; Pinedo HM
    J Immunol; 2002 Feb; 168(3):1490-5. PubMed ID: 11801694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells.
    van der Vliet HJ; Molling JW; Nishi N; Masterson AJ; Kölgen W; Porcelli SA; van den Eertwegh AJ; von Blomberg BM; Pinedo HM; Giaccone G; Scheper RJ
    Cancer Res; 2003 Jul; 63(14):4101-6. PubMed ID: 12874013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection.
    Motsinger A; Haas DW; Stanic AK; Van Kaer L; Joyce S; Unutmaz D
    J Exp Med; 2002 Apr; 195(7):869-79. PubMed ID: 11927631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells.
    Marschner A; Rothenfusser S; Hornung V; Prell D; Krug A; Kerkmann M; Wellisch D; Poeck H; Greinacher A; Giese T; Endres S; Hartmann G
    Eur J Immunol; 2005 Aug; 35(8):2347-57. PubMed ID: 16025562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load.
    Molling JW; Kölgen W; van der Vliet HJ; Boomsma MF; Kruizenga H; Smorenburg CH; Molenkamp BG; Langendijk JA; Leemans CR; von Blomberg BM; Scheper RJ; van den Eertwegh AJ
    Int J Cancer; 2005 Aug; 116(1):87-93. PubMed ID: 15756674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: analysis of human V alpha 24+CD8+ NK T cells activated by alpha-galactosylceramide-pulsed monocyte-derived dendritic cells.
    Takahashi T; Chiba S; Nieda M; Azuma T; Ishihara S; Shibata Y; Juji T; Hirai H
    J Immunol; 2002 Apr; 168(7):3140-4. PubMed ID: 11907064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection.
    Lucas M; Gadola S; Meier U; Young NT; Harcourt G; Karadimitris A; Coumi N; Brown D; Dusheiko G; Cerundolo V; Klenerman P
    J Virol; 2003 Feb; 77(3):2251-7. PubMed ID: 12525661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes.
    Gadola SD; Dulphy N; Salio M; Cerundolo V
    J Immunol; 2002 Jun; 168(11):5514-20. PubMed ID: 12023346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insufficient ex vivo expansion of Valpha24(+) natural killer T cells in malignant lymphoma patients related to the suppressed expression of CD1d molecules on CD14(+) cells.
    Imataki O; Heike Y; Makiyama H; Iizuka A; Ikarashi Y; Ishida T; Wakasugi H; Takaue Y
    Cytotherapy; 2008; 10(5):497-506. PubMed ID: 18608348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer.
    Kita H; Naidenko OV; Kronenberg M; Ansari AA; Rogers P; He XS; Koning F; Mikayama T; Van De Water J; Coppel RL; Kaplan M; Gershwin ME
    Gastroenterology; 2002 Oct; 123(4):1031-43. PubMed ID: 12360465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells.
    Motsinger A; Azimzadeh A; Stanic AK; Johnson RP; Van Kaer L; Joyce S; Unutmaz D
    J Virol; 2003 Jul; 77(14):8153-8. PubMed ID: 12829854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.
    Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H
    Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel recognition motif of human NKT antigen receptor for a glycolipid ligand.
    Kawano T; Tanaka Y; Shimizu E; Kaneko Y; Kamata N; Sato H; Osada H; Sekiya S; Nakayama T; Taniguchi M
    Int Immunol; 1999 Jun; 11(6):881-7. PubMed ID: 10360961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Va24Vb11 natural killer T cells in Wilsonian hepatitis.
    Kinebuchi M; Matsuura A; Ohya K; Abo W; Kitazawa J
    Clin Exp Immunol; 2005 Jan; 139(1):144-51. PubMed ID: 15606625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells.
    Durante-Mangoni E; Wang R; Shaulov A; He Q; Nasser I; Afdhal N; Koziel MJ; Exley MA
    J Immunol; 2004 Aug; 173(3):2159-66. PubMed ID: 15265953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells are targets for human invariant Valpha24+ natural killer T-cell cytotoxic activity: an important immune regulatory function.
    Nicol A; Nieda M; Koezuka Y; Porcelli S; Suzuki K; Tadokoro K; Durrant S; Juji T
    Exp Hematol; 2000 Mar; 28(3):276-82. PubMed ID: 10720692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.